Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

The anti-PD1 therapy is approved for more than 41 indications in the U.S., and the latest approval marks its first indication in malignant pleural mesothelioma.

The following is a summary of “Multimodality Therapy Including Pleurectomy/Decortication in Pleural Mesothelioma: Long-Term ...

The following is a summary of “Rapid Pleurodesis in Patients With Chronic Noninfectious Pleural Effusion,” published in the ...

New York: The McGraw-Hill Company, 2009. Sugarbaker DJ, Norberto JJ, Swanson SJ. Surgical staging and work-up of patients with diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg.

You can see details of the main clinical trial on the UCL website. HIT-Meso aims to find out how well a new therapy, called Proton Beam Therapy, can be used to treat pleural mesothelioma patients.

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

Suggested remit: To appraise the clinical and cost effectiveness of pembrolizumab with pemetrexed and platinum-based chemotherapy within its marketing authorisation for untreated unresectable advanced ...

and malignant pleural disease including mesothelioma. His PhD, funded by the NIHR Doctoral Research Fellowship programme, focused on novel management of pleural infection to reduce the burden on ...